Immuneering (IMRX) Accumulated Expenses (2020 - 2026)
Immuneering's Accumulated Expenses was $4.09 million in Q2 2026, down 9.3% from $4.51 million a year earlier but up 33.6% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Immuneering came in at $7.84 million, up 57.7% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of 62.2% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $4.97 million in FY2024 (-3.9%), $5.17 million in FY2023 (+15.0%), $4.5 million in FY2022 (+13.5%) and $3.97 million in FY2021 (+467.3%).
- Quarterly Accumulated Expenses has moved between $1.72 million (Q1 2022) and $7.84 million (Q4 2025) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in five of the last eight quarters, with growth averaging 23.5%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q4 2021 (growth of 467.3%); the worst was Q2 2022 (a decline of 32.9%).
- Per Business Quant data, IMRX's Accumulated Expenses in the three quarters before Q2 2026 was $3.06 million (Q1 2026), $7.84 million (Q4 2025) and $7.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Immuneering | 264.61 Mn | 264.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.09 Mn |
| Mar 31, 2026 | 3.06 Mn |
| Dec 31, 2025 | 7.84 Mn |
| Sep 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | 4.51 Mn |
| Mar 31, 2025 | 3.39 Mn |
| Dec 31, 2024 | 4.97 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Jun 30, 2024 | 3.76 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 2.43 Mn |
| Mar 31, 2023 | 2.41 Mn |
| Dec 31, 2022 | 4.50 Mn |
| Sep 30, 2022 | 4.56 Mn |
| Jun 30, 2022 | 2.23 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 3.97 Mn |
| Sep 30, 2021 | 3.39 Mn |
API Access
Immuneering Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();